Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Military Medicine|January 27, 2011
The phantom limb experience and sensory phenomena in a relocated limb in a case of fillet flap used to reconstruct a massive wound proximal to an above-knee amputationDouglas B Price, Richard B Rosse, Joseph W Henry, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|August 3, 2002
Repetitive transcranial magnetic stimulation treatment of comorbid posttraumatic stress disorder and major depressionPaul B Rosenberg, Ritula B Mehndiratta, Yash P Mehndiratta, et al.
The Israel Journal of Psychiatry and Related Sciences|August 6, 2010
Regulation of intermittent oscillatory activity of pyramidal cell neurons by GABA inhibitory interneurons is impaired in schizophrenia: rationale for pharmacotherapeutic GABAergic interventionsStephen I Deutsch, Richard B Rosse, Barbara L Schwartz, et al.
Clinical Neuropharmacology|February 28, 2008
First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategyStephen I Deutsch, Barbara L Schwartz, Nina R Schooler, et al.
Journal of Clinical and Experimental Neuropsychology|November 9, 2002
Source monitoring in alcoholismBarbara L Schwartz, Elizabeth S Parker, Stephen I Deutsch, et al.
International Journal of Psychiatry in Medicine|June 5, 2003
Fluoxetine's effects on cognitive performance in patients with traumatic brain injuryStefanie A Horsfield, Richard B Rosse, Vincent Tomasino, et al.
Clinical Neuropharmacology|August 5, 2003
Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophreniaStephen I Deutsch, Barbara L Schwartz, Richard B Rosse, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 2008
Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801's pharmacologic actionStephen I Deutsch, Richard B Rosse, Katrice D Long, et al.
The Israel Journal of Psychiatry and Related Sciences|September 2, 2005
Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophreniaStephen I Deutsch, Richard B Rosse, Barbara L Schwartz, et al.
CNS Spectrums|May 23, 2008
Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinolStephen I Deutsch, Richard B Rosse, Julie M Connor, et al.
Pageof 5